Literature DB >> 4147710

Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics.

J V Ananth, T A Ban, H E Lehmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4147710     DOI: 10.1177/070674377301800505

Source DB:  PubMed          Journal:  Can Psychiatr Assoc J        ISSN: 0008-4824


× No keyword cloud information.
  4 in total

1.  Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Authors:  Yukiko Tomioka; Shusuke Numata; Makoto Kinoshita; Hidehiro Umehara; Shin-Ya Watanabe; Masahito Nakataki; Yoshimi Iwayama; Tomoko Toyota; Masashi Ikeda; Hidenaga Yamamori; Shinji Shimodera; Atsushi Tajima; Ryota Hashimoto; Nakao Iwata; Takeo Yoshikawa; Tetsuro Ohmori
Journal:  J Psychiatry Neurosci       Date:  2018-05       Impact factor: 6.186

Review 2.  Combined vitamin B6-magnesium treatment in autism spectrum disorder.

Authors:  C Nye; A Brice
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

3.  Clinical features of schizophrenia with enhanced carbonyl stress.

Authors:  Mitsuhiro Miyashita; Makoto Arai; Akiko Kobori; Tomoe Ichikawa; Kazuya Toriumi; Kazuhiro Niizato; Kenichi Oshima; Yuji Okazaki; Takeo Yoshikawa; Naoji Amano; Toshio Miyata; Masanari Itokawa
Journal:  Schizophr Bull       Date:  2013-09-23       Impact factor: 9.306

4.  Natural Medicines for Psychotic Disorders: A Systematic Review.

Authors:  H J Rogier Hoenders; Agna A Bartels-Velthuis; Nina K Vollbehr; Richard Bruggeman; Henderikus Knegtering; Joop T V M de Jong
Journal:  J Nerv Ment Dis       Date:  2018-02       Impact factor: 2.254

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.